Compound: WIN 55212-2
SMILES: O=C(c1c2c(ccc1)cccc2)c3c4c5c(OC[C@H](n5c3C)CN6CCOCC6)ccc4
InChIKey: HQVHOQAKMCMIIM-HXUWFJFHSA-N
Synonyms: WIN 55212-2, Win-55212-2, 131543-22-1, Win 55,212, 5H31GI9502, WIN55212-2, J442.901J, CHEBI:73295, Win-552122, (R)-WIN-55212, (R)-(+)-WIN-55212-2, [(11R)-2-methyl-11-(morpholin-4-ylmethyl)-9-oxa-1-azatricyclo[6.3.1.04,12]dodeca-2,4(12),5,7-tetraen-3-yl]-naphthalen-1-ylmethanone, Methanone, ((3R)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo(1,2,3-de)-1,4-benzoxazin-6-yl)-1-naphthalenyl-, Methanone, (2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo(1,2,3-de)-1,4-benzoxazin-6-yl)-1-naphthalenyl-, (+)-, WIN-55212, [(3R)-5-methyl-3-(morpholin-4-ylmethyl)-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl](1-naphthyl)methanone, WIN 55212, ((11R)-2-methyl-11-(morpholin-4-ylmethyl)-9-oxa-1-azatricyclo(6.3.1.04,12)dodeca-2,4(12),5,7-tetraen-3-yl)-naphthalen-1-ylmethanone, ((3R)-5-methyl-3-(morpholin-4-ylmethyl)-2,3-dihydro(1,4)oxazino(2,3,4-hi)indol-6-yl)(1-naphthyl)methanone, (11R)-2-methyl-11-(morpholin-4-ylmethyl)-3-((naphthalen-1-yl)carbonyl)-9-oxa-1-azatricyclo(6.3.1.0^(4,12))dodeca-2,4,6,8(12)-tetraene, (11R)-2-methyl-11-(morpholin-4-ylmethyl)-3-[(naphthalen-1-yl)carbonyl]-9-oxa-1-azatricyclo[6.3.1.0^{4,12}]dodeca-2,4,6,8(12)-tetraene, RefChem:902217, WIN 55.212-2, WIN 55,212-2, CHEMBL188, (R)-(+)-Win 55212-2, {(3R)-5-methyl-3-[(morpholin-4-yl)methyl]-2,3-dihydro[1,4]oxazino[2,3,4-hi]indol-6-yl}(naphthalen-1-yl)methanone, (2,3-Dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl)methanone, (r)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone, UNII-5H31GI9502, WI5, WIN55,212-2, WIN-2, Lopac0_001278, BSPBio_001538, GTPL733, SCHEMBL118531, SCHEMBL29361053, SCHEMBL29381882, BDBM21281, DTXSID40894849, HQVHOQAKMCMIIM-HXUWFJFHSA-N, HMS1791M20, HMS1989M20, CCG-205351, DB13950, SDCCGSBI-0051244.P002, WIN 55212 2, NCGC00016210-02, NCGC00016210-03, NCGC00016210-04, NCGC00016210-05, NCGC00016210-06, NCGC00016210-07, NCGC00016210-08, NCGC00161310-01, NCGC00161310-02, NCGC00161310-03, NCGC00161310-04, NCGC00161310-05, NS00098698, Q4016981, BRD-K88282786-001-02-0, BRD-K88282786-066-04-9, (11R)-2-methyl-11-(morpholin-4-ylmethyl)-3-(naphthalen-1-ylcarbonyl)-9-oxa-1-azatricyclo[6.3.1.0^{4,12}]dodeca-2,4(12),5,7-tetraene, (2,3-dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl)methanone monomethanesulfonat, (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenylmethanone mesylate, 6H-Pyrrolo(3,2,1-ij)quinolin-6-one, 4,5-dihydro-2-methyl-4-(4-morpholinylmethyl)-1-(1-naphthalenylcarbonyl)-, (R)-, WIN 55,212-2; Methanone, [(3R)-2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenyl-; Methanone, [2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo[1,2,3-de]-1,4-benzoxazin-6-yl]-1-naphthalenyl-, (R)-; Pyrrolo[1,2,3-de]-1,
Theoretical properties:
molecular_formula: C27H26N2O3
molecular_weight: 426.5 g/mol
exact_mass: 426.19434270 g/mol
formal_charge: 0
hydrogen_bond_donor_count: 0
hydrogen_bond_acceptor_count: 4
rotatable_bond_count: 4
heavy_atom_count: 32
topological_polar_surface_area: 43.7 Å²
isotope_atom_count: 0
covalently_bonded_unit_count: 1
Physical properties:
Descriptions:
pubchem: WIN 55212-2 is a organic heterotricyclic compound that is 5-methyl-3-(morpholin-4-ylmethyl)-2,3-dihydro[1,4]oxazino[2,3,4-hi]indole substituted at position 6 by a 1-naphthylcarbonyl group. It has a role as an analgesic, a neuroprotective agent and an apoptosis inhibitor. It is an organic heterotricyclic compound, a member of morpholines, a naphthyl ketone and a synthetic cannabinoid.
chebi: A organic heterotricyclic compound that is 5-methyl-3-(morpholin-4-ylmethyl)-2,3-dihydro[1,4]oxazino[2,3,4-<em>hi</em>]indole substituted at position 6 by a 1-naphthylcarbonyl group.
chembl: WIN-552122 is a small molecule listed in the ChEMBL database but has not progressed to an approved clinical phase.
wikipedia: LY-235959 is a competitive antagonist at the NMDA receptor. It has analgesic and neuroprotective effects and causes hypothermia in animal models, as well as reducing the development of tolerance to morphine and altering the reinforcing effects of cocaine.